ATE518536T1 - Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium) propionathydrogenfumarat und dihydrogenphosphat - Google Patents

Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium) propionathydrogenfumarat und dihydrogenphosphat

Info

Publication number
ATE518536T1
ATE518536T1 AT08857026T AT08857026T ATE518536T1 AT E518536 T1 ATE518536 T1 AT E518536T1 AT 08857026 T AT08857026 T AT 08857026T AT 08857026 T AT08857026 T AT 08857026T AT E518536 T1 ATE518536 T1 AT E518536T1
Authority
AT
Austria
Prior art keywords
propionathydrogene
trimethylhydrazinium
fumarate
dihydrogen phosphate
medical use
Prior art date
Application number
AT08857026T
Other languages
English (en)
Inventor
Ilmars Stonans
Eduard Tararak
Elena Andreyeva
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40481525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE518536(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Application granted granted Critical
Publication of ATE518536T1 publication Critical patent/ATE518536T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT08857026T 2007-12-04 2008-12-03 Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium) propionathydrogenfumarat und dihydrogenphosphat ATE518536T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07122272 2007-12-04
EP07122273 2007-12-04
PCT/EP2008/066711 WO2009071585A1 (en) 2007-12-04 2008-12-03 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate

Publications (1)

Publication Number Publication Date
ATE518536T1 true ATE518536T1 (de) 2011-08-15

Family

ID=40481525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08857026T ATE518536T1 (de) 2007-12-04 2008-12-03 Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium) propionathydrogenfumarat und dihydrogenphosphat

Country Status (32)

Country Link
US (1) US20100234459A1 (de)
EP (1) EP2222293B1 (de)
JP (1) JP2011505408A (de)
KR (1) KR20100084688A (de)
CN (1) CN101951898B (de)
AR (1) AR069521A1 (de)
AT (1) ATE518536T1 (de)
AU (1) AU2008333262A1 (de)
BR (1) BRPI0819057A2 (de)
CA (1) CA2706354C (de)
CL (1) CL2008003551A1 (de)
CO (1) CO6280477A2 (de)
CY (1) CY1112336T1 (de)
DK (1) DK2222293T3 (de)
DO (1) DOP2010000163A (de)
EA (1) EA019424B1 (de)
GE (1) GEP20125673B (de)
HR (1) HRP20110744T1 (de)
IL (1) IL205961A0 (de)
MA (1) MA31993B1 (de)
MX (1) MX2010006255A (de)
MY (1) MY150508A (de)
PA (1) PA8805901A1 (de)
PE (1) PE20091037A1 (de)
PL (1) PL2222293T3 (de)
PT (1) PT2222293E (de)
RS (1) RS51992B (de)
SI (1) SI2222293T1 (de)
TN (1) TN2010000250A1 (de)
TW (1) TW200930356A (de)
WO (1) WO2009071585A1 (de)
ZA (1) ZA201003641B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2425835A1 (de) * 2010-08-18 2012-03-07 Grindeks, a joint stock company Neuartige medizinische Verwendung von 3-(2,2,2-Trimethylhydrazinium)propionat-Dihydrat und natürlichen Flavonoid-Derivaten
TWI487524B (zh) * 2010-12-03 2015-06-11 Tetra Sia 菸鹼酸和米曲肼之新穎治療組合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386014T1 (de) * 2003-08-04 2008-03-15 Grindeks Jsc Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung

Also Published As

Publication number Publication date
CA2706354C (en) 2013-08-13
CN101951898B (zh) 2012-12-05
AR069521A1 (es) 2010-01-27
PE20091037A1 (es) 2009-08-19
DOP2010000163A (es) 2010-08-31
EP2222293A1 (de) 2010-09-01
TN2010000250A1 (en) 2011-11-11
US20100234459A1 (en) 2010-09-16
HRP20110744T1 (hr) 2011-11-30
CO6280477A2 (es) 2011-05-20
BRPI0819057A2 (pt) 2015-05-05
AU2008333262A1 (en) 2009-06-11
DK2222293T3 (da) 2011-11-21
JP2011505408A (ja) 2011-02-24
EP2222293B1 (de) 2011-08-03
MX2010006255A (es) 2011-03-15
GEP20125673B (en) 2012-10-25
TW200930356A (en) 2009-07-16
WO2009071585A1 (en) 2009-06-11
CY1112336T1 (el) 2015-12-09
KR20100084688A (ko) 2010-07-27
RS51992B (en) 2012-04-30
MA31993B1 (fr) 2011-01-03
MY150508A (en) 2014-01-30
PA8805901A1 (es) 2009-07-23
PL2222293T3 (pl) 2012-01-31
SI2222293T1 (sl) 2011-12-30
EA019424B1 (ru) 2014-03-31
ZA201003641B (en) 2011-03-30
CN101951898A (zh) 2011-01-19
EA201000738A1 (ru) 2011-04-29
IL205961A0 (en) 2010-11-30
PT2222293E (pt) 2011-11-15
CA2706354A1 (en) 2009-06-11
CL2008003551A1 (es) 2010-01-22

Similar Documents

Publication Publication Date Title
DE602007011908D1 (de) Verwendung von gpr119-rezeptoragonisten zur vermehrung der knochenmasse und zur behandlung von osteoporose sowie kombinationstherapie dafür
DE602006010401D1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
DE502005007427D1 (de) 3-aminoindazole derivate und ihre verwendung zur behandlung sgk-bedingten krankheiten
ATE439863T1 (de) Ophthalmische zusammensetzungen von parasympathischen stimulantia und entzündungshemmer zur verwendung bei der behandlung von presbyopie
ATE447559T1 (de) 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3- carboxamid derivate als mek inhibitoren zur behandlung von hyperproliferativen erkrankungen
ATE512948T1 (de) Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen
EA201071245A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс
DE502005003904D1 (de) Tetrahydrobenzo (d) azepin-2-on derivate und ihre verwendung zur behandlung von kardiovaskulären krankheiten
FR2939033B1 (fr) Composition cosmetique de maquillage et/ou de soin des matieres keratiniques, et procede de maquillage
DE602006019468D1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
ATE467633T1 (de) 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung
FR2934147B1 (fr) Implant d'osteosynthese vertebrale
BRPI0923747A2 (pt) "tratamento de safras transgênicas com misturas de fiprolas e cloroniconilas".
DE602006012469D1 (de) Bipolare medizinische elektrodenanordnung mit kanüle und entfernbarer anschlusselektrode
ATE495179T1 (de) Tetrahydropyridothienpyrimidin-verbindungen und verwendung zur behandlung proliferativer erkrankungen
ATE486597T1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
ATE509621T1 (de) Verwendung von 2,5-dihydroxybenzolderivaten zur behandlung von arthritis und schmerzen
ATE483460T1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE602006007323D1 (de) VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN
ATE540682T1 (de) Kombination von triazin-derivaten und insulin- sekretionsstimulatoren
ATE540023T1 (de) Neuartige 3-aminoalkyl-1,3-dihydro-2h-indol-2-on- derivate, ihre herstellung und therapeutische verwendung
DE602004023543D1 (de) Implantierbare medizinische vorrichtung
ATE541831T1 (de) Verwendung von indolderivaten als nurr-1- aktivatoren zur behandlung von morbus parkinson
DE602005005145D1 (de) Medizinische Elektrodenanordnung mit Möglichkeit zur Überwachung der Behandlung
DK1867352T3 (da) Anatomisk implanterbar hjerteprotese i ét stykke

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2222293

Country of ref document: EP